Kush Parmar

Affiliations

  • Large Shareholder at Skye Bioscience Inc. (SKYE), 2024-03-15
  • Large Shareholder at Enliven Therapeutics Inc. (ELVN), 2024-02-16
  • Director at Rallybio Corp (RLYB), 2024-01-04
  • Large Shareholder, Director at Entrada Therapeutics Inc. (TRDA), 2023-06-12
  • Large Shareholder at Cincor Pharma Inc. (CINC), 2023-02-28
  • Large Shareholder, Director at Akouos Inc. (AKUS), 2022-12-02
  • Director at Homology Medicines Inc. (FIXX), 2022-06-17
  • Large Shareholder, Director at Vor Biopharma Inc. (VOR), 2022-06-16
  • Large Shareholder at Cabaletta Bio Inc. (CABA), 2021-11-03
  • Large Shareholder at Impel Neuropharma Inc (IMPL), 2021-04-30
  • Co-Ceo at 5:01 Acquisition Corp. (FVAM), 2020-12-01
  • Other at Aprea Therapeutics Inc. (APRE), 2020-10-08
  • Director at Arvinas Inc. (ARVN), 2019-09-26
  • Director at Scpharmaceuticals Inc. (SCPH), 2018-06-21
  • Director at Audentes Therapeutics Inc. (BOLD), 2018-06-08
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TRDA $20.00 250,000 Large Shareholder, Director 1,132,357 2021-11-02 Filing
RLYB $13.00 615,384 Director 1,406,098 2021-08-02 Filing
VOR $18.00 444,444 Large Shareholder, Director 1,858,470 2021-02-09 Filing
VOR $18.00 111,111 Large Shareholder, Director 4,833,959 2021-02-09 Filing
AKUS $17.00 294,117 Large Shareholder, Director 1,094,101 2020-06-30 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RLYB $8.20 100,000 Director 2,378,969 2023-03-07 Filing
RLYB $12.50 50,329 Large Shareholder, Director 1,251,755 2022-06-03 Filing
RLYB $12.50 99,671 Large Shareholder, Director 2,478,969 2022-06-03 Filing
RLYB $13.00 33,553 Large Shareholder, Director 1,302,084 2022-05-23 Filing
RLYB $13.00 66,447 Large Shareholder, Director 2,578,640 2022-05-23 Filing